Lebanon API manufacturing site (LEAP district)
Eli Lilly and Company, Lebanon, Boone County, Indiana
Lebanon API manufacturing site (LEAP district) in Lebanon, Indiana is Eli Lilly and Company’s plant for tirzepatide active pharmaceutical ingredient. Status: under construction as of May 6, 2026 (construction started). Eli Lilly and Company announced $9.0 billion and 900 jobs. Primary source: investor.lilly.com, checked November 1, 2026.
- Status
- Under construction
- Announced investment
- $9.0 billion
- Announced jobs
- 900
- Industry
- Pharmaceuticals
- Sheet
- IN-11
- Revised
- November 1, 2026
Status timeline
- Announcedinvestor.lilly.com
- Construction startedinvestor.lilly.com
Filled dots are confirmed by a company, state, SEC or federal source. Dashed dots come from news reports only. Investment and job figures are as announced, not achieved.
Plant facts
| Company | Eli Lilly and Company |
|---|---|
| Plant | Lebanon API manufacturing site (LEAP district) |
| Location | Lebanon, Boone County, Indiana |
| Industry | Pharmaceuticals |
| Product | Tirzepatide active pharmaceutical ingredient |
| Announced investment | $9.0 billionTotal for the Lebanon API site after May 2024 increase ($3.7B prior + $5.3B); 2022 announcement was $2.1B for two sites |
| Announced jobs | 900 |
| Last checked | November 1, 2026 |
Sources
- Lilly plans $2.1B in new Indiana sites (company release, investor.lilly.com, checked November 1, 2026)
- Lilly increases Lebanon investment to $9B (company release, investor.lilly.com, checked November 1, 2026)
- Lilly commits additional $4.5B in Indiana (company release, investor.lilly.com, checked November 1, 2026)
Something changed? Send a correction with a link and we'll recheck it.